Allan Guildford Brown

Title: Allan Guildford Brown: Innovator in Pharmaceutical Chemistry

Introduction

Allan Guildford Brown is a notable inventor based in Cranleigh, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Brown has focused on developing compounds with potential therapeutic applications.

Latest Patents

Brown's latest patents include groundbreaking work on azabicycloheptanes and antibacterial substituted azetidinones. The first patent involves compounds of the formula ##STR1## and their various salts and esters. These compounds feature a range of substituents, including hydrogen, alkyl groups, and carboxylic acid groups. The second patent focuses on substituted azetidinones that exhibit antibacterial activity, along with their pharmaceutically acceptable salts and esters. A representative compound from this patent is methyl 3-(2'-hydroxyethyl)-7-oxo-1-aza-4-oxabicyclo[3,2,0]-heptane-2-carboxylate, with a recommended daily dosage ranging from 50 to 6,000 mg.

Career Highlights

Allan Guildford Brown has been associated with Beecham Group Plc, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of pharmaceutical compounds and their applications in medicine.

Collaborations

Brown has collaborated with notable colleagues, including Thomas T Howarth and David F Corbett. These partnerships have fostered a collaborative environment that encourages innovation and the development of new pharmaceutical solutions.

Conclusion

Allan Guildford Brown's contributions to pharmaceutical chemistry through his patents highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic compounds, showcasing the importance of innovation in healthcare.